Contact
Please use this form to send email to PR contact of this press release:
Inventiva receives FDA Breakthrough Therapy designation for lead drug candidate lanifibranor in NASH
TO:
Please use this form to send email to PR contact of this press release:
Inventiva receives FDA Breakthrough Therapy designation for lead drug candidate lanifibranor in NASH
TO: